GO:0086092 regulation of the force of heart contraction by cardiac conduction: Cardiac Inotropy, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0086092 describes how the cardiac conduction process modulates the force with which the heart propels blood, linking electrical activation to mechanical output.
• The term sits at the intersection of excitation-contraction coupling, myofilament calcium sensitivity, and conduction velocity, so it is distinct from generic heart contraction terms.
• Cardiac calcium channels, ryanodine receptors, myosin heavy chains, and small-conductance calcium-activated potassium channels are central molecular players in this process.
• Human iPSC-derived cardiomyocytes with metabolic maturation media provide a physiologically relevant platform to study conduction-dependent inotropy.
• Dysregulation of this process contributes to arrhythmias, heart failure, and neuromuscular disorders with cardiac involvement.
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate genes in this pathway.
Description
GO:0086092, regulation of the force of heart contraction by cardiac conduction, is a biological process that captures how the spread of electrical excitation through the heart modulates the strength of contraction, thereby changing the force with which blood is propelled. This term is not simply about the heart beating; it specifically addresses the conduction-dependent tuning of contractile force, a phenomenon that integrates ion channel activity, calcium handling, and myofilament responsiveness. For researchers, this ontology term provides a precise way to annotate genes and pathways that couple electrical activation to mechanical output, which is essential for understanding cardiac physiology and disease. The process is experimentally tractable in human induced pluripotent stem cell-derived cardiomyocytes, where metabolic maturation improves physiological function and enables interrogation of conduction-contraction coupling. Because conduction velocity and contractile force are both modulated by ion channels and calcium signaling, this term is highly relevant to arrhythmia research and to the development of antiarrhythmic therapies.
regulation of the force of heart contraction by cardiac conduction At A Glance
| GO ID | GO:0086092 |
|---|---|
| GO term | regulation of the force of heart contraction by cardiac conduction |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the force of heart contraction through cardiac conduction, changing the force with which blood is propelled |
| Related process | Cardiac excitation-contraction coupling and myofilament calcium sensitivity |
| Key molecular players | Voltage-gated calcium channels, ryanodine receptors, myosin heavy chains, small-conductance Ca2+-activated K+ channels |
| Experimental platform | Human iPSC-derived cardiomyocytes with metabolic maturation |
| Disease relevance | Arrhythmias, heart failure, neuromuscular disorders with cardiac involvement |
What Is GO:0086092?
According to the QuickGO definition, GO:0086092 is a cardiac conduction process that modulates the extent of heart contraction, changing the force with which blood is propelled. In other words, it is the regulatory link between the electrical signal that spreads through the heart and the mechanical strength of the resulting contraction, rather than the contraction itself or the conduction itself in isolation.
Why Is regulation of the force of heart contraction by cardiac conduction Important in Cell Biology?
Understanding GO:0086092 is important because the force of cardiac contraction is not fixed; it is dynamically tuned by the conduction process, and this tuning is essential for matching cardiac output to physiological demand. When this regulation fails, the heart may contract too weakly or too forcefully, contributing to arrhythmias, heart failure, and other cardiovascular pathologies. Moreover, because conduction-dependent inotropy involves calcium channels, myofilament sensitivity, and mitochondrial signaling, it is a convergence point for multiple disease mechanisms and therapeutic targets.
• It links electrical conduction to mechanical output, a core principle of cardiac physiology.
• It is distinct from generic contraction terms and enables precise gene annotation.
• Dysregulation contributes to arrhythmias and heart failure.
• It is relevant to neuromuscular disorders with cardiac involvement.
• It provides a framework for testing antiarrhythmic therapies.
• It can be modeled in human iPSC-derived cardiomyocytes.
• It involves calcium channel nanoscale organization.
• It is modulated by myofilament calcium sensitivity.
• It intersects with mitochondrial and mitokine signaling.
• It is amenable to CRISPR-based causal gene testing.
What Happens During regulation of the force of heart contraction by cardiac conduction?
Initiation of cardiac conduction
In simple terms: The electrical signal starts in the heart's pacemaker and spreads to working muscle cells.
Cardiac conduction begins with the generation of an action potential that propagates through the specialized conduction system and into the working myocardium. This electrical wave is the trigger that ultimately determines when and how forcefully the heart contracts. The conduction process itself is shaped by ion channels, including voltage-gated calcium channels whose nanoscale organization regulates calcium entry.
Excitation-contraction coupling
In simple terms: The electrical signal tells the muscle cell to release calcium, which drives contraction.
During excitation-contraction coupling, membrane depolarization opens voltage-gated calcium channels, allowing calcium influx that triggers ryanodine receptor-mediated calcium release from the sarcoplasmic reticulum. This calcium transient is the proximate signal for myofilament activation, and its amplitude and kinetics influence the force of contraction. Small-conductance Ca2+-activated K+ channels also participate in shaping the action potential and calcium handling, bridging mitochondrial and sarcolemmal signaling.
Modulation of myofilament calcium sensitivity
In simple terms: The muscle proteins can become more or less responsive to calcium, changing contraction strength.
The force of contraction is not determined by calcium alone; myofilament calcium sensitivity modulates how strongly the contractile apparatus responds to a given calcium concentration. Changes in calcium sensitivity can alter both the magnitude and the kinetics of contraction and relaxation in vivo. The super-relaxed state of cardiac beta-myosin, studied by molecular dynamics simulations, provides a structural basis for how myosin heads are recruited during contraction.
Conduction-dependent inotropic regulation
In simple terms: The speed and pattern of the electrical signal can change how hard the heart squeezes.
The conduction process itself can modulate contractile force; for example, changes in activation sequence or conduction velocity can alter the timing and synchrony of contraction, thereby affecting the force with which blood is propelled. This is the essence of GO:0086092: a cardiac conduction process that modulates the extent of heart contraction. Neurohumoral and optogenetic approaches have been used to dissect these regulatory inputs.
Metabolic and mitochondrial influences
In simple terms: The energy status of the cell can fine-tune how conduction affects contraction.
Mitochondrial function and metabolic maturation influence cardiac physiological function, including excitation-contraction coupling. Small-conductance Ca2+-activated K+ channels bridge mitochondria, sarcolemma, and antiarrhythmic therapy, highlighting the integration of metabolic and electrical signals. The unfolded protein response and mitokine signaling also contribute to myocardial injury repair and may indirectly affect contractile regulation.
Key Genes Involved in GO:0086092 regulation of the force of heart contraction by cardiac conduction
The following genes and proteins are central to the regulation of the force of heart contraction by cardiac conduction, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MYH7 | Cardiac beta-myosin heavy chain; super-relaxed state modulates contraction | Target for point mutations and molecular dynamics studies |
| MYH6 | Cardiac alpha-myosin heavy chain; contractile apparatus | Knockout and knock-in models for contractility |
| CACNA1C | Voltage-gated L-type calcium channel; calcium entry | Knockout and point mutation to study conduction-contraction coupling |
| RYR2 | Ryanodine receptor; sarcoplasmic reticulum calcium release | Knock-in models for calcium leak and arrhythmia |
| KCNN2 | Small-conductance Ca2+-activated K+ channel; action potential shaping | Knockout and overexpression for antiarrhythmic studies |
| KCNN3 | Small-conductance Ca2+-activated K+ channel; repolarization | Knockout models for arrhythmia susceptibility |
| TNNT2 | Cardiac troponin T; myofilament calcium sensitivity | Point mutations to alter calcium sensitivity |
| TNNI3 | Cardiac troponin I; inhibitory subunit of troponin | Knock-in for contractile regulation |
| TPM1 | Tropomyosin; thin filament regulation | Overexpression and knockout for myofilament function |
| ACTC1 | Cardiac actin; thin filament | Point mutations for contractile dysfunction |
| MYBPC3 | Myosin binding protein C; sarcomere structure | Knockout and knock-in for hypertrophic cardiomyopathy |
| SCN5A | Voltage-gated sodium channel; conduction velocity | Knockout and point mutation for conduction slowing |
| ATP2A2 | SERCA2a; calcium reuptake | Overexpression for relaxation and force modulation |
| PLN | Phospholamban; SERCA2a regulation | Knockout and point mutation for calcium handling |
| NPPA | Atrial natriuretic peptide; neurohumoral regulation | Overexpression for cardiac stress responses |
| NPPB | B-type natriuretic peptide; cardiac stress marker | Knockout for heart failure models |
| ADRB1 | Beta-1 adrenergic receptor; neurohumoral control | Knockout and overexpression for inotropic regulation |
| ADRB2 | Beta-2 adrenergic receptor; neurohumoral control | Point mutation for signaling studies |
How Is regulation of the force of heart contraction by cardiac conduction Regulated?
The regulation of the force of heart contraction by cardiac conduction is modulated by neurohumoral inputs, including adrenergic signaling, which can alter both conduction velocity and contractile strength. Optogenetic approaches have been used to dissect these neurohumoral cardiac regulatory circuits. At the cellular level, calcium channel nanoscale organization and dynamic reorganization provide a layer of regulation that tunes calcium entry and thus contraction force. Myofilament calcium sensitivity is another key regulatory node, allowing the contractile apparatus to respond differently to the same calcium signal. Metabolic maturation media can improve the physiological function of human iPSC-derived cardiomyocytes, suggesting that metabolic state regulates the coupling between conduction and contraction. Mitochondrial and mitokine signaling pathways also influence myocardial function and may indirectly regulate contractile force.
regulation of the force of heart contraction by cardiac conduction and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN5A | Arrhythmia and conduction slowing | Knockout or point-mutation iPSC-derived cardiomyocytes |
| KCNN2 | Arrhythmia susceptibility | Knockout and overexpression models |
| MYH7 | Hypertrophic cardiomyopathy and contractile dysfunction | Point-mutation knock-in for super-relaxed state |
| RYR2 | Calcium leak and arrhythmia | Knock-in for calcium handling defects |
| TNNT2 | Altered myofilament calcium sensitivity | Point-mutation knock-in for contractile regulation |
Arrhythmias and conduction disorders
Disruption of the regulation of the force of heart contraction by cardiac conduction can lead to arrhythmias, as altered conduction and calcium handling change the timing and strength of contraction. Small-conductance Ca2+-activated K+ channels are emerging as antiarrhythmic targets because they bridge mitochondrial, sarcolemmal, and electrical signaling. Mutations in SCN5A and calcium channel genes can slow conduction and predispose to arrhythmia.
Heart failure and contractile dysfunction
Heart failure involves impaired contractile force and often dysregulated calcium handling and myofilament sensitivity. Changes in the super-relaxed state of cardiac beta-myosin can affect contractile efficiency and are studied as a mechanism of disease. Metabolic and mitochondrial dysfunction also contribute to myocardial injury and contractile failure.
Neuromuscular disorders with cardiac involvement
Muscle satellite cell dysfunction in neuromuscular disorders can extend to cardiac muscle, affecting contractile regulation. Although the primary pathology is skeletal muscle, cardiac conduction and contraction can be secondarily affected in these conditions.
From regulation of the force of heart contraction by cardiac conduction-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a calcium channel gene alter conduction-dependent force? | Knockout iPSC-derived cardiomyocytes |
| Does a specific myosin mutation change the super-relaxed state? | Point-mutation knock-in in cardiomyocytes |
| Can a disease-associated variant be corrected to restore contractility? | Knock-in correction via CRISPR |
| Does overexpression of SERCA2a enhance relaxation and force? | Overexpression in human iPSC-derived cardiomyocytes |
| How does a tagged channel protein localize during conduction? | Tagged knock-in for imaging |
| Does metabolic maturation affect conduction-contraction coupling? | Metabolic maturation media in iPSC-derived cardiomyocytes |
How to Study the regulation of the force of heart contraction by cardiac conduction Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Calcium imaging | Intracellular calcium transients | Assess excitation-contraction coupling |
| Patch-clamp electrophysiology | Action potential and ion currents | Measure conduction and repolarization |
| Traction force microscopy | Contractile force | Quantify inotropic effects |
| Molecular dynamics simulation | Myosin super-relaxed state | Predict mutation effects |
| Optogenetics | Light-controlled electrical activity | Dissect neurohumoral regulation |
| Metabolic maturation media | Physiological function of iPSC-CMs | Improve conduction-contraction coupling |
| Mitokine profiling | Mitochondrial stress signaling | Link metabolism to contractile regulation |
Calcium imaging and electrophysiology
Calcium imaging and patch-clamp electrophysiology are used to measure calcium transients and action potentials, which are the proximate drivers of conduction-dependent contractile force. These methods can be applied to human iPSC-derived cardiomyocytes to assess how genetic perturbations alter excitation-contraction coupling.
Contractility assays
Contractility assays, such as traction force microscopy or video-based edge detection, measure the force of contraction in cardiomyocytes or engineered heart tissues. These assays are essential for quantifying the functional output of GO:0086092 and for testing the effects of gene knockouts or mutations.
Molecular dynamics simulations
Molecular dynamics simulations can explore the super-relaxed state of cardiac beta-myosin and predict how mutations affect myosin head recruitment and contractile force. This computational approach complements experimental studies of myofilament function.
Optogenetics and neurohumoral modulation
Optogenetic tools allow precise control of cardiac electrical activity and neurohumoral regulation, enabling dissection of how conduction changes alter contractile force. These methods are useful for studying the regulatory inputs to GO:0086092.
How CRISPR Can Be Used to Study GO:0086092 regulation of the force of heart contraction by cardiac conduction
Knockout
CRISPR knockout of genes such as CACNA1C, RYR2, or KCNN2 in human iPSC-derived cardiomyocytes can reveal their causal role in conduction-dependent contractile force. Knockout models are particularly useful for testing whether a gene is required for the regulation of the force of heart contraction by cardiac conduction.
Point Mutation
Point mutations can be introduced into genes like MYH7 or TNNT2 to model disease-associated variants and assess their impact on myofilament calcium sensitivity and contractile force. These models help distinguish pathogenic from benign variants in the context of GO:0086092.
Knock-in
Knock-in of reporter tags or disease alleles allows precise tracking of protein localization and function during conduction-contraction coupling. For example, tagging calcium channels can reveal their nanoscale organization in cardiomyocytes.
Overexpression
Overexpression of genes such as ATP2A2 or ADRB1 can enhance or perturb contractile force and relaxation, providing gain-of-function insights into the regulation of cardiac contraction by conduction. Overexpression models complement loss-of-function studies to define the full dynamic range of the pathway.
How EDITGENE Supports regulation of the force of heart contraction by cardiac conduction Research
Researchers studying regulation of the force of heart contraction by cardiac conduction-related genes often need to determine whether a candidate gene is causally involved in modulating contractile force, and CRISPR-based models provide the most direct way to test this. EDITGENE offers a suite of services tailored to this need, from knockout to overexpression and library screening, enabling rigorous functional dissection of GO:0086092.
Contact EDITGENE today to design your custom CRISPR model for regulation of the force of heart contraction by cardiac conduction research.
Frequently Asked Questions About regulation of the force of heart contraction by cardiac conduction
What is GO:0086092?
GO:0086092 is the Gene Ontology term for regulation of the force of heart contraction by cardiac conduction, a biological process in which cardiac conduction modulates the extent of heart contraction, changing the force with which blood is propelled.
What genes are involved in regulation of the force of heart contraction by cardiac conduction?
Key genes include MYH7, MYH6, CACNA1C, RYR2, KCNN2, KCNN3, TNNT2, TNNI3, TPM1, ACTC1, MYBPC3, SCN5A, ATP2A2, PLN, NPPA, NPPB, ADRB1, and ADRB2.
How does cardiac conduction regulate the force of heart contraction?
Cardiac conduction triggers calcium entry and release, which activates myofilaments; the conduction process can also modulate the timing and synchrony of contraction, thereby changing the force with which blood is propelled.
What is the role of calcium channels in GO:0086092?
Voltage-gated calcium channels mediate calcium entry that initiates excitation-contraction coupling, and their nanoscale organization regulates the efficiency of this process.
How can I study regulation of the force of heart contraction by cardiac conduction in the lab?
Human iPSC-derived cardiomyocytes with metabolic maturation, combined with calcium imaging, contractility assays, and CRISPR gene editing, are widely used to study this process.
What diseases are associated with defects in this process?
Arrhythmias, heart failure, and neuromuscular disorders with cardiac involvement are associated with dysregulation of conduction-dependent contractile force.
What is the super-relaxed state of cardiac myosin?
The super-relaxed state is a conformational state of cardiac beta-myosin that affects the availability of myosin heads for contraction and can be studied by molecular dynamics simulations.
How do small-conductance Ca2+-activated K+ channels contribute to this process?
They shape the action potential and calcium handling, bridging mitochondrial, sarcolemmal, and antiarrhythmic signaling.
Can CRISPR be used to model GO:0086092-related diseases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models in cardiomyocytes enable causal testing of genes involved in conduction-dependent contractile regulation.
What experimental models are best for studying conduction-contraction coupling?
Human iPSC-derived cardiomyocytes, especially with metabolic maturation, are a leading model because they recapitulate physiological function and can be genetically edited.
Conclusion
GO:0086092, regulation of the force of heart contraction by cardiac conduction, captures a critical physiological link between electrical activation and mechanical output in the heart. Its molecular underpinnings involve calcium channels, myofilament proteins, and potassium channels, and its dysregulation contributes to arrhythmias and heart failure. Advances in human iPSC-derived cardiomyocyte models and CRISPR gene editing now allow researchers to dissect this process with unprecedented precision, accelerating the discovery of therapeutic targets.
References
- 1. Feyen DAM et al.. 2020. Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes.. Cell Rep 32(3):107925 PMID: 32697997
- 2. Ganassi M et al.. 2022. Involvement of muscle satellite cell dysfunction in neuromuscular disorders: Expanding the portfolio of satellite cell-opathies.. Eur J Transl Myol 32(1) PMID: 35302338
- 3. Li M et al.. 2024. Exploring the Super-Relaxed State of Human Cardiac β-Myosin by Molecular Dynamics Simulations.. J Phys Chem B 128(13):3113-3120 PMID: 38516963
- 4. Terentyev D et al.. 2026. Small-conductance Ca(2)⁺-activated K⁺ channels in cardiac excitation-contraction coupling: Bridging mitochondria, sarcolemma and antiarrhythmic therapy.. J Physiol 604(16):6691-6703 PMID: 41347808
- 5. Scalco A et al.. 2021. Neurohumoral Cardiac Regulation: Optogenetics Gets Into the Groove.. Front Physiol 12:726895 PMID: 34531763
- 6. Chung JH et al.. 2016. Myofilament Calcium Sensitivity: Role in Regulation of In vivo Cardiac Contraction and Relaxation.. Front Physiol 7:562 PMID: 28018228
- 7. Dixon RE. 2021. Nanoscale Organization, Regulation, and Dynamic Reorganization of Cardiac Calcium Channels.. Front Physiol 12:810408 PMID: 35069264
- 8. Gao W et al.. 2025. UPRmt-regulated mitokines: novel strategies for myocardial injury repair.. Front Cell Dev Biol 13:1652353 PMID: 41234361
